A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
University of Pittsburgh
Maastricht University Medical Center
University Hospital Augsburg
Case Comprehensive Cancer Center
Philogen S.p.A.
Philogen S.p.A.
Jules Bordet Institute
Helsinki University Central Hospital
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
VA Office of Research and Development
Henry Ford Health System